statins

Biotech By Adam Feuerstein, Meg Tirrell and Damian Garde

Biotech stocks are a dumpster fire. An analyst explains what’s going on

First Opinion By Yonatan Adiri

Antigen testing has some serious problems. Done right, it could reshape the future of health care

First Opinion By Krista Lyn Harrison, Meridith Greene and Anthony Galanos

We all need help working through grief and hardship

Biotech By Matthew Herper

Did veteran drug developer Hal Barron accomplish his mission at GSK?

Health Tech By Casey Ross

‘We must change’: Health systems invest more aggressively than ever in digital health

Pharma By Matthew Herper

They built a smarter approach to Covid clinical trials. Now they want to do the same for other diseases

First Opinion By Christopher Hartnick

Using force crossed my mind when examining a defiant young patient. A short story made me take a breath

Health Tech By Casey Ross

The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter